Dermapharm Holding SE
XETRA:DMP

Watchlist Manager

Dermapharm Holding SE

XETRA:DMP

Watchlist

Dividends

Discount Rate

Price: 34 EUR 8.63% Market Closed

Market Cap: 1.8B EUR

Have any thoughts about
Dermapharm Holding SE?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 34 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

DMP Alert

Dermapharm Holding SE

+2.7 (+8.63%)

52 Week Range	30.15 42.7
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Dermapharm Holding SE

What unique competitive advantages
does Dermapharm Holding SE hold over its rivals?

What risks and challenges
does Dermapharm Holding SE face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Dermapharm Holding SE.

What unique competitive advantages
does Dermapharm Holding SE hold over its rivals?

What risks and challenges
does Dermapharm Holding SE face in the near future?

Has there been any significant insider trading activity
in Dermapharm Holding SE recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dermapharm Holding SE.

Provide P/S
for Dermapharm Holding SE.

Provide P/E
for Dermapharm Holding SE.

Provide P/OCF
for Dermapharm Holding SE.

Provide P/FCFE
for Dermapharm Holding SE.

Provide P/B
for Dermapharm Holding SE.

Provide EV/S
for Dermapharm Holding SE.

Provide EV/GP
for Dermapharm Holding SE.

Provide EV/EBITDA
for Dermapharm Holding SE.

Provide EV/EBIT
for Dermapharm Holding SE.

Provide EV/OCF
for Dermapharm Holding SE.

Provide EV/FCFF
for Dermapharm Holding SE.

Provide EV/IC
for Dermapharm Holding SE.

Show me price targets
for Dermapharm Holding SE made by professional analysts.

What are the Revenue projections
for Dermapharm Holding SE?

How accurate were the past Revenue estimates
for Dermapharm Holding SE?

What are the Net Income projections
for Dermapharm Holding SE?

How accurate were the past Net Income estimates
for Dermapharm Holding SE?

What are the EPS projections
for Dermapharm Holding SE?

How accurate were the past EPS estimates
for Dermapharm Holding SE?

What are the EBIT projections
for Dermapharm Holding SE?

How accurate were the past EBIT estimates
for Dermapharm Holding SE?

Compare the revenue forecasts
for Dermapharm Holding SE with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dermapharm Holding SE and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dermapharm Holding SE against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dermapharm Holding SE compared to its peers.

Compare the P/E ratios
of Dermapharm Holding SE against its peers.

Discuss the investment returns and shareholder value creation
comparing Dermapharm Holding SE with its peers.

Analyze the financial leverage
of Dermapharm Holding SE compared to its main competitors.

Show all profitability ratios
for Dermapharm Holding SE.

Provide ROE
for Dermapharm Holding SE.

Provide ROA
for Dermapharm Holding SE.

Provide ROIC
for Dermapharm Holding SE.

Provide ROCE
for Dermapharm Holding SE.

Provide Gross Margin
for Dermapharm Holding SE.

Provide Operating Margin
for Dermapharm Holding SE.

Provide Net Margin
for Dermapharm Holding SE.

Provide FCF Margin
for Dermapharm Holding SE.

Show all solvency ratios
for Dermapharm Holding SE.

Provide D/E Ratio
for Dermapharm Holding SE.

Provide D/A Ratio
for Dermapharm Holding SE.

Provide Interest Coverage Ratio
for Dermapharm Holding SE.

Provide Altman Z-Score Ratio
for Dermapharm Holding SE.

Provide Quick Ratio
for Dermapharm Holding SE.

Provide Current Ratio
for Dermapharm Holding SE.

Provide Cash Ratio
for Dermapharm Holding SE.

What is the historical Revenue growth
over the last 5 years for Dermapharm Holding SE?

What is the historical Net Income growth
over the last 5 years for Dermapharm Holding SE?

What is the current Free Cash Flow
of Dermapharm Holding SE?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dermapharm Holding SE.

DMP

Balance Sheet

Current Portion of Long-Term Debt

Dermapharm Holding SE
Current Portion of Long-Term Debt

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Dermapharm Holding SE
Current Portion of Long-Term Debt Peer Comparison

Comparables:

ATAI

BAYN

MRK

93M1

PSG

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

	Current Portion of Long-Term Debt	CAGR 3Y	CAGR 5Y	CAGR 10Y
Dermapharm Holding SE XETRA:DMP	Current Portion of Long-Term Debt €116.5m	CAGR 3-Years 91%	CAGR 5-Years 15%	CAGR 10-Years N/A
ATAI Life Sciences NV NASDAQ:ATAI	Current Portion of Long-Term Debt N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Bayer AG XETRA:BAYN	Current Portion of Long-Term Debt €9.2B	CAGR 3-Years 35%	CAGR 5-Years 7%	CAGR 10-Years 10%
Merck KGaA XETRA:MRK	Current Portion of Long-Term Debt €2.9B	CAGR 3-Years -4%	CAGR 5-Years -10%	CAGR 10-Years 3%
MPH Health Care AG XETRA:93M1	Current Portion of Long-Term Debt €7.4k	CAGR 3-Years 23%	CAGR 5-Years -39%	CAGR 10-Years N/A
PharmaSGP Holding SE XETRA:PSG	Current Portion of Long-Term Debt €8.2m	CAGR 3-Years 224%	CAGR 5-Years 100%	CAGR 10-Years N/A

What is Dermapharm Holding SE's Current Portion of Long-Term Debt?

Current Portion of Long-Term Debt
116.5m EUR

Based on the financial report for Jun 30, 2024, Dermapharm Holding SE's Current Portion of Long-Term Debt amounts to 116.5m EUR.

What is Dermapharm Holding SE's Current Portion of Long-Term Debt growth rate?

Current Portion of Long-Term Debt CAGR 5Y
15%

Over the last year, the Current Portion of Long-Term Debt growth was 150%. The average annual Current Portion of Long-Term Debt growth rates for Dermapharm Holding SE have been 91% over the past three years , 15% over the past five years .

Dermapharm Holding SE
XETRA:DMP

Dermapharm Holding SE
Current Portion of Long-Term Debt

Dermapharm Holding SE
Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

See Also

What is Dermapharm Holding SE's Current Portion of Long-Term Debt?

Current Portion of Long-Term Debt
116.5m EUR

What is Dermapharm Holding SE's Current Portion of Long-Term Debt growth rate?

Current Portion of Long-Term Debt CAGR 5Y
15%

Company

Help

Tools

Stocks

Dermapharm Holding SE XETRA:DMP

Dermapharm Holding SE Current Portion of Long-Term Debt

Dermapharm Holding SE Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis Latest Figures & CAGR of Competitors

See Also

What is Dermapharm Holding SE's Current Portion of Long-Term Debt? Current Portion of Long-Term Debt 116.5m EUR

What is Dermapharm Holding SE's Current Portion of Long-Term Debt growth rate? Current Portion of Long-Term Debt CAGR 5Y 15%

Company

Help

Tools

Stocks

Dermapharm Holding SE
XETRA:DMP

Dermapharm Holding SE
Current Portion of Long-Term Debt

Dermapharm Holding SE
Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

What is Dermapharm Holding SE's Current Portion of Long-Term Debt?

Current Portion of Long-Term Debt
116.5m EUR

What is Dermapharm Holding SE's Current Portion of Long-Term Debt growth rate?

Current Portion of Long-Term Debt CAGR 5Y
15%